Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
Endocrinology and Metabolism Clinics of North America|May 23, 2021
Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of AgentsDominik Saul, Matthew T Drake
Bone|December 15, 2016
Hormonal and systemic regulation of sclerostinMatthew T Drake, Sundeep Khosla
Endocrinology and Metabolism Clinics of North America|August 11, 2012
Male osteoporosisMatthew T Drake, Sundeep Khosla
British Journal of Clinical Pharmacology|February 7, 2019
The skeletal impact of cancer therapiesLucia Bedatsova, Matthew T Drake
Current Osteoporosis Reports|January 3, 2012
Potential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosisWei Zhang, Matthew T Drake
Mayo Clinic Proceedings|March 15, 2023
Incidence, Risk Factors, and Outcomes of Incident Atrial Fibrillation in Patients With Graves DiseaseJwan A Naser, Sorin V Pislaru, Marius N Stan, et al.
The Journal of Clinical Endocrinology and Metabolism|December 25, 2021
Nonsurgical Management of Thyroid Nodules: The Role of Ablative TherapiesMarius N Stan, Maria Papaleontiou, John J Schmitz, et al.
Thyroid : Official Journal of the American Thyroid Association|March 6, 2026
Beyond the Eyes: Is Teprotumumab Effective for Thyroid Dermopathy?Dana Hamadi, Suhail Saad-Omer, David Toro-Tobon, et al.
Bonekey Reports|March 1, 2014
Clinical utility of serum sclerostin measurementsBart L Clarke, Matthew T Drake
Pageof 18